X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs DR. REDDYS LAB - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON DR. REDDYS LAB BIOCON /
DR. REDDYS LAB
 
P/E (TTM) x 41.9 26.1 160.7% View Chart
P/BV x 7.3 3.6 200.9% View Chart
Dividend Yield % 0.2 0.7 21.9%  

Financials

 BIOCON    DR. REDDYS LAB
EQUITY SHARE DATA
    BIOCON
Mar-18
DR. REDDYS LAB
Mar-18
BIOCON /
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,1882,788 42.6%   
Low Rs3051,902 16.0%   
Sales per share (Unadj.) Rs68.7860.8 8.0%  
Earnings per share (Unadj.) Rs7.657.1 13.2%  
Cash flow per share (Unadj.) Rs14.0122.0 11.5%  
Dividends per share (Unadj.) Rs1.0020.00 5.0%  
Dividend yield (eoy) %0.10.9 15.7%  
Book value per share (Unadj.) Rs86.3757.7 11.4%  
Shares outstanding (eoy) m600.00165.91 361.6%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x10.92.7 398.7%   
Avg P/E ratio x98.941.1 240.6%  
P/CF ratio (eoy) x53.419.2 278.0%  
Price / Book Value ratio x8.63.1 279.4%  
Dividend payout %13.235.0 37.8%   
Avg Mkt Cap Rs m447,900389,034 115.1%   
No. of employees `0006.123.5 26.1%   
Total wages/salary Rs m9,31132,149 29.0%   
Avg. sales/employee Rs Th6,705.86,070.8 110.5%   
Avg. wages/employee Rs Th1,514.21,366.6 110.8%   
Avg. net profit/employee Rs Th736.9402.5 183.1%   
INCOME DATA
Net Sales Rs m41,234142,810 28.9%  
Other income Rs m2,0621,552 132.9%   
Total revenues Rs m43,296144,362 30.0%   
Gross profit Rs m8,29123,512 35.3%  
Depreciation Rs m3,85110,772 35.8%   
Interest Rs m615788 78.0%   
Profit before tax Rs m5,88713,504 43.6%   
Minority Interest Rs m2130-   
Prior Period Items Rs m0344 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5694,380 35.8%   
Profit after tax Rs m4,5319,468 47.9%  
Gross profit margin %20.116.5 122.1%  
Effective tax rate %26.732.4 82.2%   
Net profit margin %11.06.6 165.7%  
BALANCE SHEET DATA
Current assets Rs m41,486104,984 39.5%   
Current liabilities Rs m21,41368,938 31.1%   
Net working cap to sales %48.725.2 192.9%  
Current ratio x1.91.5 127.2%  
Inventory Days Days6474 86.0%  
Debtors Days Days94104 90.9%  
Net fixed assets Rs m50,661104,385 48.5%   
Share capital Rs m3,000830 361.4%   
"Free" reserves Rs m48,808124,886 39.1%   
Net worth Rs m51,808125,716 41.2%   
Long term debt Rs m17,89825,089 71.3%   
Total assets Rs m99,897225,443 44.3%  
Interest coverage x10.618.1 58.3%   
Debt to equity ratio x0.30.2 173.1%  
Sales to assets ratio x0.40.6 65.2%   
Return on assets %5.24.5 113.2%  
Return on equity %8.77.5 116.1%  
Return on capital %9.69.7 99.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05872,623 16.6%   
Fx outflow Rs m7,34818,916 38.8%   
Net fx Rs m4,71053,707 8.8%   
CASH FLOW
From Operations Rs m6,62118,030 36.7%  
From Investments Rs m-6,840-14,883 46.0%  
From Financial Activity Rs m-2,397-4,440 54.0%  
Net Cashflow Rs m-2,612-1,236 211.3%  

Share Holding

Indian Promoters % 40.4 25.5 158.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 5.4 155.6%  
FIIs % 10.7 35.3 30.3%  
ADR/GDR % 0.0 18.5 -  
Free float % 19.9 15.3 130.1%  
Shareholders   109,995 75,885 144.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  MERCK  GSK PHARMA  

Compare BIOCON With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and IT Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector and IT sector.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

This is Why You Need to Buy Small Cap Stocks Now(The 5 Minute Wrapup)

Mar 15, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Mar 20, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS